SBIR Phase I: Viral inactivation in air and on surfaces across large areas by safe, non-thermal, non-ionizing electromagnetic radiation

SBIR 第一阶段:通过安全、非热、非电离电磁辐射灭活空气中和大面积表面上的病毒

基本信息

  • 批准号:
    2036664
  • 负责人:
  • 金额:
    $ 25.44万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
    Standard Grant
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-07-01 至 2022-06-30
  • 项目状态:
    已结题

项目摘要

The broader impact/commercial potential of this Small Business Innovation Research (SBIR) project is a new and safe non-contact method and device to inactivate viruses in air or on surfaces and objects. The non-chemical method proposed is scalable and can be quickly adjusted to target novel pathogens and therefore prevent or mitigate future epidemics of novel viral pathogens. The solution enabled by the proposed project is a relatively low-cost portable or ceiling-mounted device to be operated in health care settings, offices, schools, public transit, or other locations where the risk of disease transmission is high. The device would provide a continuous antiviral effect in thousands or millions of locations while operating within safe limits for human exposure. This SBIR Phase I project proposes to validate the concept of a non-contact viral inactivation method that relies on resonant energy transfer from microwaves, and to demonstrate the efficacy in viral assays under operation parameters that are safe for humans and within regulatory guidelines. To accomplish this, a miniaturized and cost-effective high power pulsed microwave source and antenna is required. To this end, a prototype device will be developed that consists of a high-power vacuum electronics device, such as a magnetron or a traveling-wave tube, a custom and novel high voltage power source, and firmware and controls. The power supply will be designed to drive an existing vacuum device, by means of a regulated high-voltage output in the kilowatt range and a floating low-power auxiliary power source. To control pulsed operation, a control algorithm will be implemented in a microcontroller. The prototype will be characterized and used to expose viral samples in common viral growth assays, followed by a quantitative assessment of the antiviral effect. The outcome expected is a functional prototype that achieves significant reduction, e.g., 2 logs, within safe limits that will serve as a blueprint for a novel class of antiviral devices.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
该小企业创新研究 (SBIR) 项目更广泛的影响/商业潜力是一种新型安全的非接触式方法和设备,可灭活空气中或表面和物体上的病毒。所提出的非化学方法具有可扩展性,可以快速调整以针对新型病原体,从而预防或减轻新型病毒病原体未来的流行。拟议项目提供的解决方案是一种成本相对较低的便携式或吸顶式设备,可在医疗机构、办公室、学校、公共交通或其他疾病传播风险较高的场所运行。该设备将在数千或数百万个地点提供持续的抗病毒作用,同时在人体暴露的安全范围内运行。 该 SBIR 第一阶段项目旨在验证依赖于微波共振能量转移的非接触式病毒灭活方法的概念,并证明在对人类安全且符合监管指南的操作参数下病毒检测的有效性。为了实现这一目标,需要小型化且具有成本效益的高功率脉冲微波源和天线。为此,将开发一种原型设备,该设备由高功率真空电子设备(例如磁控管或行波管)、定制的新型高压电源以及固件和控制器组成。该电源将设计用于通过千瓦范围内的稳压高压输出和浮动低功率辅助电源来驱动现有的真空设备。为了控制脉冲操作,将在微控制器中实施控制算法。该原型将被表征并用于在常见的病毒生长测定中暴露病毒样本,然后对抗病毒效果进行定量评估。预期的结果是一个功能原型,在安全限度内实现显着减少,例如 2 对数,这将作为新型抗病毒设备的蓝图。该奖项反映了 NSF 的法定使命,并通过使用评估被认为值得支持基金会的智力价值和更广泛的影响审查标准。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Luke Raymond其他文献

Low mass RF power inverter for cubesat plasma thruster using 3D printed inductors
使用 3D 打印电感器的立方体卫星等离子体推进器的低质量射频功率逆变器
SARS-CoV-2 wastewater variant surveillance: pandemic response leveraging FDA’s GenomeTrakr network
SARS-CoV-2 废水变异监测:利用 FDA 的 GenomeTrakr 网络应对大流行
  • DOI:
  • 发表时间:
    2024
  • 期刊:
  • 影响因子:
    0
  • 作者:
    R. Timme;Jacquelina Woods;Jessica L. Jones;Kevin R. Calci;Rachel Rodriguez;Candace Barnes;Elizabeth Leard;Mark Craven;Haifeng Chen;Cameron Boerner;Christopher Grim;Amanda Windsor;Padmini Ramachandran;T. Muruvanda;Hugh Rand;Bereket T. Tesfaldet;Jasmine Amirzadegan;Tunc Kayikcioglu;Tamara Walsky;Marc Allard;M. Balkey;C. Bias;Eric Brown;Kathryn Judy;T. Pfefer;S. Tallent;Maria Hoffmann;J. Pettengill;Ward Jacox;Dave Engelthaler;Michael Valentine;Crystal Hepp;D. Kiang;Zhirong Li;Ryan Gentry;Mary Ann Hagerman;M. Robinson;Jesse Knibbs;Madi Asbell;Beth Johnson;Logan Burns;Ashley Aurand;Joshua Stacy;Tracy Stiles;Esther Fortes;Matthew Doucette;Brandon Sabina;Luc Gagne;Kelly Binns;M. Pandori;A. Gorzalski;Lauryn Massic;Sarmila Dasgupta;Amar Patil;A. Panyi;Edward Acheampong;Thomas Kirn;Nicholas Palmateer;Willis Fedio;Yatziri Preciado;Srikanth Paladugu;S. Thakur;Lyndy Harden;Luke Raymond;Melanie Prarat;Ashley Sawyer;Jonah Perkins;Edward G. Dudley;Jasna Kovac;N. M’ikanatha;Erin M. Nawrocki;Yezhi Fu;Nyduta Mbogo;Kristin Carpenter;Richard C. Huard;Sean Sierra;Megan Davis;Laura M. Lane;Christy A. Jeffcoat;Gregory Goodwin;Gabrielle Godfrey;Andrew Smith;Chukwuemika Aroh;Kirsti R. Gilmore;Jessica Freeman;Joy Scaria;Jane Hennings;Eric Nelson;Yan Sun;Bonnie Oh;Michael Jost;Bryan Brooks;Laura Langan;Lauren Turner;Stephanie Dela Cruz;Jessica Maitland;Shelby Bennett;Logan Fink;Mary Toothman;Hyunsook Moon;Yong Liu;Mychal Hendrickson;Darren Lucas;Phillip Dykema;Roxanne Meek;G. Melly;Paige Sickles;Breanna McArdle;Anneke Jansen;Megan Young;Josh Arbaugh;Zachary Kuhl;Ewa King
  • 通讯作者:
    Ewa King
An Integrated RF Power Delivery and Plasma Micro-Thruster System for Nano-Satellites
用于纳米卫星的集成射频功率传输和等离子体微型推进器系统
  • DOI:
    10.3389/fphy.2018.00115
  • 发表时间:
    2018-10-12
  • 期刊:
  • 影响因子:
    3.1
  • 作者:
    Wei Liang;C. Charles;Luke Raymond;Alex Stuchbery;K. Surakitbovorn;Lei Gu;R. Boswell;J. Rivas
  • 通讯作者:
    J. Rivas
Structurally supportive RF power inverter for a CubeSat electrothermal plasma micro-thruster with PCB inductors
用于带有 PCB 电感器的 CubeSat 电热等离子体微型推进器的结构支持射频功率逆变器
Detection of (1,3)-β-d-Glucan in Cerebrospinal Fluid in Histoplasma Meningitis
组织胞浆菌性脑膜炎脑脊液中(1,3)-β-d-葡聚糖的检测
  • DOI:
  • 发表时间:
    2018
  • 期刊:
  • 影响因子:
    9.4
  • 作者:
    T. Myint;Felicia C. Chow;Karen C. Bloch;Luke Raymond;Thomas E. Davis;Patty W. Wright;Laila Woc;Raed N. Khairy;Alan C. Street;Tomotaka Yamamoto;Amanda Albers;L. J. Wheat;C. Hage
  • 通讯作者:
    C. Hage

Luke Raymond的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Luke Raymond', 18)}}的其他基金

SBIR Phase I: Novel High Voltage Pulsed Power Supplies for Nanosecond Repetitively Pulsed Plasmas
SBIR 第一阶段:用于纳秒重复脉冲等离子体的新型高压脉冲电源
  • 批准号:
    1622230
  • 财政年份:
    2016
  • 资助金额:
    $ 25.44万
  • 项目类别:
    Standard Grant

相似国自然基金

热带河口特有鱼类尖鳍鲤早期生活史不同阶段的栖息地利用变化及驱动机制
  • 批准号:
    32360917
  • 批准年份:
    2023
  • 资助金额:
    32 万元
  • 项目类别:
    地区科学基金项目
基于现代监测的湘西惹迷洞MIS2阶段石笋碳同位素和微量元素记录重建研究
  • 批准号:
    42371164
  • 批准年份:
    2023
  • 资助金额:
    51 万元
  • 项目类别:
    面上项目
高层钢结构建模-优化-深化的跨阶段智能设计方法
  • 批准号:
    52308142
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
马尾松和粘盖乳牛肝菌预共生阶段互作机制研究
  • 批准号:
    32360372
  • 批准年份:
    2023
  • 资助金额:
    32 万元
  • 项目类别:
    地区科学基金项目
低碳环境下考虑阶段间运输混合流水车间成组调度的协同智能优化方法
  • 批准号:
    72301026
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

SBIR PHASE II Point-of-Care HCV Detection
SBIR PHASE II 护理点 HCV 检测
  • 批准号:
    10935701
  • 财政年份:
    2023
  • 资助金额:
    $ 25.44万
  • 项目类别:
PA-22-176, SBIR, Phase I, Novel Bispecific Nanotherapeutics as Broad-Spectrum Influenza Antivirals Refractory to Viral Escape
PA-22-176,SBIR,I 期,新型双特异性纳米疗法,作为难以病毒逃逸的广谱流感抗病毒药物
  • 批准号:
    10698804
  • 财政年份:
    2023
  • 资助金额:
    $ 25.44万
  • 项目类别:
PA-22-176, SBIR, Phase I, Novel Bispecific Nanotherapeutics as Broad-Spectrum Influenza Antivirals Refractory to Viral Escape
PA-22-176,SBIR,I 期,新型双特异性纳米疗法,作为难以病毒逃逸的广谱流感抗病毒药物
  • 批准号:
    10698804
  • 财政年份:
    2023
  • 资助金额:
    $ 25.44万
  • 项目类别:
SBIR Phase II: Machine Learning for Rapid Automated Viral Infectivity Assays (COVID-19)
SBIR 第二阶段:用于快速自动化病毒感染性检测的机器学习 (COVID-19)
  • 批准号:
    2136850
  • 财政年份:
    2022
  • 资助金额:
    $ 25.44万
  • 项目类别:
    Cooperative Agreement
SBIR Phase II: Non-Chromatographic Method for the Purification of Viral Vectors
SBIR 第二阶段:病毒载体纯化的非色谱方法
  • 批准号:
    2132838
  • 财政年份:
    2022
  • 资助金额:
    $ 25.44万
  • 项目类别:
    Cooperative Agreement
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了